Related Experiment Videos
Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT)
Kathy L Baglan1, Michael B Sharpe, David Jaffray
1Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI 48073, USA.
International Journal of Radiation Oncology, Biology, Physics
|January 16, 2003
Summary
This study shows that accelerated partial-breast irradiation using three-dimensional conformal radiation therapy (3D-CRT) is feasible for early-stage breast cancer. A 10 mm planning target volume margin adequately covers the clinical target volume with minimal acute toxicity.
Area of Science:
- Radiation Oncology
- Medical Physics
Background:
- Early-stage breast cancer treatment often involves lumpectomy followed by radiation therapy.
- Partial-breast irradiation (PBI) aims to reduce treatment time and toxicity compared to whole-breast irradiation.
- Three-dimensional conformal radiation therapy (3D-CRT) is a precise radiation delivery technique.
Purpose of the Study:
- To present and assess the clinical feasibility of a novel 3D-CRT technique for treating the lumpectomy cavity plus a 1.5-cm margin in early-stage breast cancer patients.
- To determine an appropriate planning target volume (PTV) margin accounting for breathing motion and patient setup uncertainty.
Main Methods:
- A 3D-CRT technique for PBI was developed using archived CT scans.
- Clinical feasibility was assessed in 9 prospectively enrolled patients.
- Doses of 34 Gy or 38.5 Gy were delivered in 10 fractions over 5 days.
- The impact of breathing motion and setup uncertainty on clinical target volume (CTV) coverage was evaluated.
Main Results:
- A 5 mm "breathing-only" margin ensured 98%-100% CTV coverage by the 95% isodose line during breathing extremes.
- A total CTV-to-PTV margin of 10 mm was sufficient to cover organ motion and setup errors.
- Patient tolerance was excellent with minimal acute toxicity, including no skin changes and only mild hyperpigmentation/erythema at follow-up.
Conclusions:
- Accelerated partial-breast irradiation using 3D-CRT is technically feasible for early-stage breast cancer.
- A 10 mm CTV-to-PTV margin appears adequate for most patients.
- Further studies with more patients and longer follow-up are needed to validate the margin and assess long-term outcomes.